Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Theraclone Sciences cuts HIV antibodies deal with Gilead

Theraclone Sciences Inc. of Seattle said it's made a deal with Gilead Sciences Inc. that will allow the Foster City-based biotech giant to develop and commercialize Theraclone's neutralizing HIV-antibodies for therapeutic applications in HIV.

Published
19 hours ago
From
San Francisco Business Times (blog)
Mothers starting antiretrovirals in Malawi lost from care more frequently, revealing weaknesses in Option B+ implementation

Although Malawi’s policy of offering lifelong antiretroviral therapy (ART) to women living with HIV who are pregnant or breastfeeding resulted in a sevenfold increase in women

Published
30 July 2014
By
Carole Leach-Lemens
Switching from first-line ART with suppressed viral load linked to treatment failure

 People who switch away from their initial antiretroviral therapy (ART) regimen when their viral load is undetectable may have a higher likelihood of subsequent virological failure, researchers reported

Published
29 July 2014
By
Liz Highleyman
Of guidelines, targets and resources: the documents that defined the 2014 International AIDS Conference

If there was a phrase that defined the 20th International AIDS Conference (AIDS 2014), one that surfaced in every few presentations and kept turning up in documents,

Published
26 July 2014
By
Gus Cairns
Efavirenz use not linked to neurocognitive impairment

People who use antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also in the Atripla coformulation) were not at higher risk for impaired neurocognitive function, either overall or when looking

Published
25 July 2014
By
Liz Highleyman
Men Who Have Sex With Men Getting Treatment Sooner

Long-term trends indicate that European men who have sex with men are seeking treatment for HIV at earlier stages of their disease, researchers reported here.

Published
25 July 2014
From
MedPage Today
The Medicines Patent Pool (MPP) broadens collaboration with Gilead Sciences: Signs licence for Phase III medicine tenofovir alafenamide (TAF)

The licence will allow manufacturers in India and China to develop generic versions of TAF for 112 countries that are home to more than 92% of people living with HIV in the developing world.

Published
25 July 2014
From
Medicines Patent Pool
Strong performance on HIV drugs for mothers doesn't guarantee optimal care for infants, survey shows

The significant increase in access to antiretroviral therapy for all pregnant women living with HIV in Malawi after implementation of Option B+ contrasts with low coverage of

Published
24 July 2014
By
Carole Leach-Lemens
Dolutegravir demonstrates good efficacy despite resistance

Antiretroviral regimens containing the recently approved HIV integrase inhibitor dolutegravir (Tivicay) demonstrated high rates of viral suppression even in treatment-experienced people who had virus with resistance to

Published
24 July 2014
By
Liz Highleyman
Could HIV treatment mean safer sex?

A meta-analysis of every study that has looked at the sexual behaviour of people after starting HIV treatment has found not a single instance of so-called

Published
24 July 2014
By
Gus Cairns
← First12345...360Next →

Filter by country